<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <link rel="stylesheet" href="secondpage.css">
    <link href='https://fonts.googleapis.com/css?family=Alice' rel='stylesheet'>
    <link href='https://fonts.googleapis.com/css?family=Anton' rel='stylesheet'>
    <link rel="stylesheet" href="https://unpkg.com/boxicons@2.1.4/css/boxicons.min.css">

</head>
<body class="sb-expanded" background="images/AlzMatrix2.png"> 

    <div id="header_container">
        <div id="header">
            AlzMatrix
        </div>
    </div>

    <!-- <div id="wrapper">
        <div id="sidebar">
            <ul>
                <li>Home</li>
                <li>About Alzeihmer's</li>
                <li>Awareness & Survey</li>
                <li>Genetics</li>
                <li>Proteins & Networks</li>
                <li>Pathways</li>
                <li>Drugs & Treatments</li>
                <li>Caregiver Guide</li>
                <li>Support & Helplines</li>
            </ul>

        </div>

        <div id="main">
            <p>this is main content</p>
        </div>
    </div> -->


    <aside id="sidebar">
        
        
        <nav id="list_nav">
            <ul id="ul_list">
                <li>
                    <a href="" data-resize-btn id="button"><i class="bx bx-chevrons-right" id="button"></i></a>
                </li>
                <li>
                    <a id="list_item" href="index.html"><span id="list_span">Home</span></a>
                </li>
                <li>
                    <a id="list_item" href="#about_ad"><span id="list_span">About Alzeihmer's</span></a>
                </li>
                <li>
                    <a id="list_item" href="#aware"><span id="list_span">Awareness & Survey</span></a>
                </li>
                <li>
                    <a id="list_item" href="#genes"><span id="list_span">Genetics</span></a>
                </li>
                <li>
                    <a id="list_item" href="#proteins"><span id="list_span">Proteins & Networks</span></a>
                </li>
                <li>
                    <a id="list_item" href="#pathways"><span id="list_span">Pathways</span></a>
                </li>
                <li>
                    <a id="list_item" href="#drugs"><span id="list_span">Drugs & Treatments</span></a>
                </li>
                <li>
                    <a id="list_item" href="#guide"><span id="list_span">Caregiver Guide</span></a>
                </li>
                <li>
                    <a id="list_item" href="#support"><span id="list_span">Support & Helplines</span></a>
                </li>
            </ul>
        </nav>

        <div id="index">
            <h4>INDEX</h4>
        </div>

    </aside>

    <main id="main">
        <h1 id="title">AlzMatrix</h1>

        <hr>
        <br>

        <div id="about_ad">
            <h2 id="about_ad_h2">About Alzheimer's</h2>
            <select id="selectBox" onchange="changeFunc();">
                <option value="eng">English</option>
                <option value="mar">Marathi</option>
                <option value="hin">Hindi</option>
              </select>
            <!-- <h3 id="about_ad_h3_1">Understanding the disease</h3>
            <p id="about_ad_p1">Alzheimer‚Äôs Disease (AD) is a progressive neurodegenerative disorder that primarily affects memory, thinking, and behavior. It is the most common cause of dementia, impacting millions worldwide.
            </p>
            <h3 id="about_ad_h3_2">What happens in AD</h3>
            <p id="about_ad_p2">Accumulation of beta-amyloid plaques and tau tangles in the brain.
                Loss of neuronal connections and brain cell death.
                Gradual decline in cognitive functions, leading to memory loss and confusion.
                </p>
            <h3 id="about_ad_h3_3">Why does it matter?</h3>
            <p id="about_ad_p3">No cure currently exists, and treatments only manage symptoms.
                Early detection can help slow disease progression and improve quality¬†of¬†life.</p> -->

            
            <h3 id="about_ad_h3_4">Summary of the paper on Alzheimer‚Äôs Disease</h3>
            <ol id="about_ad_ol">
                <li><h4 id="about_ad_h4_1">Population Impact</h4>
                    <p id="about_ad_p_1">Globally, 32.3 million people have Alzheimer's dementia (11.4 million men, 20.9 million women).<br>
                        In Europe, 6.9 million people are affected (1.9 million men, 5.0 million women).<br>
                        In the U.S., 6.9 million Americans aged 65+ have AD, projected to reach 13.8 million by 2060 without medical breakthroughs.</p>
                </li>
                <li><h4 id="about_ad_h4_2">Disease Overview</h4>
                    <p id="about_ad_p_2">Alzheimer‚Äôs disease (AD) is a neurodegenerative disorder marked by:<br>

                        Œ≤-amyloid (AŒ≤) plaques and hyperphosphorylated tau (pTau) tangles<br>
                        Memory loss and cognitive decline<br>
                        Unclear disease mechanisms and lack of treatments to halt progression
                        </p>
                </li>
                <li><h4 id="about_ad_h4_3">Risk Factors</h4>
                    <ul>
                        <li><p id="about_ad_p_3">‚úÖGenetics:<br>
                        APOE4 is the strongest genetic risk factor for AD.<br>
                            Familial AD (FAD) is linked to mutations in APP, PSEN1, and PSEN2 genes.
                            </p>
                        </li>
                        <li><p id="about_ad_p_4">‚úÖEnvironmental & Metabolic Factors:<br>
                            Aging, inflammation, infections, diabetes, and lifestyle factors contribute to AD.
                            </p>
                        </li>
                    </ul>
                </li>
                <li><h4 id="about_ad_h4_4">Pathology & Mechanisms</h4>
                    <p id="about_ad_p_5">AŒ≤ Accumulation: Impaired clearance leads to neurotoxicity and inflammation.<br>
                        Tau Pathology: Abnormal tau aggregation spreads neurodegeneration.<br>
                        Neuroinflammation: Microglial activation plays a role in disease progression.
                        </p>
                </li>
                <li><h4 id="about_ad_h4_5">Diagnosis & Drug Development</h4>
                    <p id="about_ad_p_6">üî¨Biomarkers: Studied in CSF (Cerebrospinal fluid) and peripheral blood.<br>
                        üíä Current Drugs: Cholinesterase inhibitors and NMDA antagonists only manage symptoms.<br>
                        üß™ Emerging Therapies: AŒ≤-targeting drugs and tau-focused treatments.
                        </p>
                </li>
                <li><h4 id="about_ad_h4_6">APOE4 & Alzheimer‚Äôs Disease</h4>
                    <p id="about_ad_p_7">üîπ APOE4 affects lipid transport, neurovascular function, and microglial activity.<br>
                        üîπ Carriers have an increased risk and earlier onset of AD.<br>
                        üîπ Targeting APOE4 could lead to new therapeutic strategies.
                        </p>
                </li>
                <li><h4 id="about_ad_h4_7">Sex Differences in Alzheimer‚Äôs Disease</h4>
                    <p id="about_ad_p_8">üí° Women are more affected than men due to biological differences:<br>
                        Hormones: Estrogen decline post-menopause increases risk.<br>
                        Genetics: X chromosome-linked genes play a role.<br>
                        Metabolism: Age-related Y chromosome loss is linked to neurodegeneration.<br>
                        Research Bias: Historically male-focused, but tools like XWAS now uncover sex-specific genetic factors.
                    </p>
                </li>
                <li><h4 id="about_ad_h4_8">Epigenetic Clocks & Alzheimer‚Äôs Disease</h4>
                    <p id="about_ad_p_9">üß¨ Epigenetic clocks measure biological aging through DNA methylation patterns:<br>
                        üìå First-generation clocks (Hannum, Horvath) estimate age but have limitations.<br>
                        üìå Second-generation clocks (PhenoAge, GrimAge) predict health risks and lifespan.<br>
                        üìå Third-generation clocks (DunedinPoAm, DunedinPACE) track biological aging rate.<br>
                        üìå Brain-specific clocks (DNAmClockCortical, PCBrainAge) detect changes linked to neurodegeneration.
                    </p>
                </li>
            </ol>

            <img id="about_img" src="images/about_eng.jpg" alt="">

            <h4>References</h4>
            <p style="font-size: 14px;">
                Krishnamurthy HK, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C, Rajasekaran JJ. 
                <b>An overview of the genes and biomarkers in Alzheimer's disease.</b> Ageing Res Rev. 2025 Feb;104:102599. 
                doi: 10.1016/j.arr.2024.102599. Epub 2024 Nov 28. PMID: 39612989.<br><br>


                Zheng Q, Wang X. <b>Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy.</b> 
                Protein Cell. 2025 Feb 1;16(2):83-120. doi: 10.1093/procel/pwae026. PMID: 38733347; PMCID: PMC11786724.<br><br>


                Liu E, Zhang Y, Wang JZ. <b>Updates in Alzheimer's disease: from basic research to diagnosis and therapies.</b> 
                Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x. PMID: 39232848; 
                PMCID: PMC11373277. (DIAGNOSIS)<br><br>


                Lopez-Lee C, Torres ERS, Carling G, Gan L. <b>Mechanisms of sex differences in Alzheimer's disease.</b>
                Neuron. 2024 Apr 17;112(8):1208-1221. doi: 10.1016/j.neuron.2024.01.024. Epub 2024 Feb 22. 
                PMID: 38402606; PMCID: PMC11076015. (SEX DIFFERENCES)<br><br>

                Villa C, Combi R. <b>Epigenetics in Alzheimer's Disease: A Critical Overview. </b>Int J Mol Sci. 
                2024 May 29;25(11):5970. doi: 10.3390/ijms25115970. PMID: 38892155; PMCID: PMC11173284. (EPIGENETICS)<br><br>

            </p>

        
        </div>

        <hr>

        <div id="aware">
            <h2 id="aware_h2">Awareness & Survey</h2>
            
            <h3 id="aware_h3_1">Survey insights and the need for awareness</h3>

            <select id="selectBox2" onchange="changeFunc2();">
                <option value="eng">English</option>
                <option value="mar">Marathi</option>
                <option value="hin">Hindi</option>
              </select><br><br>
            <a id="survey_form" href="https://docs.google.com/forms/d/e/1FAIpQLSf1Qo3veVBKrddcrHKCTvaTiHQCVi0uPwscwUhgrA3FA7Ocig/viewform?usp=header">Fill Survey Form in English</a>
            <h3 id="aware_h3_2">Survey Evaluation</h3>

            <table id="pie_table">
                <td><div id="piechart"></div></td>
                <td><div id="pie_index">
                    <ul>
                        <li id="aware_li1">Good 154/205 :   24.9% <span id="topic" style="background-color: rgb(93, 0, 103);"></span></li>
                        <li id="aware_li2">Poor 51/205 :    75.1% <span id="topic" style="background-color: rgb(204, 0, 245);"></span></li>                    </ul>
                </div></td>
            </table>

            <img id="bar_chart" src="images/barchart.jpg" alt="">

            <br>

            <iframe id="excel" src="https://docs.google.com/spreadsheets/d/e/2PACX-1vQ74wCC07UPTKp6LDgj2RJAR5zOXy7xBnPYxe-usBwbx4OoOt7iPDifdPAORWttrsbyppCI_W58D0nC/pubhtml?gid=0&amp;single=true&amp;widget=true&amp;headers=false"></iframe>

            <p>The survey assessed public awareness and misconceptions about Alzheimer's disease. The results indicate <b>widespread misconceptions</b> regarding the disease's causes, symptoms, and management.</p>
            <ul>
                <li>Basic Understanding:
                    <ul>
                        <li>42% correctly identified that Alzheimer's is a type of dementia with no cure, while 58% were incorrect.</li>
                        <li>Only 37% knew that people in their 30s can have Alzheimer's.</li>
                        <li>24.4% falsely believed Alzheimer's could result from black magic or a bad eye.</li>
                    </ul>
                </li>

                <li>Risk Factors & Prevention:
                    <ul>
                        <li>73% were unaware that high blood pressure or cholesterol increases Alzheimer‚Äôs risk.
                        </li>
                        <li>Only 12% knew that mental exercise does not fully prevent Alzheimer's.
                        </li>
                        <li>46% recognized that poor nutrition can worsen symptoms.
                        </li>
                    </ul>
                </li>
                <li>
                    Symptoms & Diagnosis:
                    <ul>
                        <li>63% did not know trouble handling money could be an early symptom.
                        </li>
                        <li>75% mistakenly believed sudden confusion is likely due to Alzheimer's.
                        </li>
                        <li>72% falsely thought people with Alzheimer's remember recent events better than older ones.
                        </li>
                    </ul>
                </li>
                <li>
                    Treatment & Care:
                    <ul>
                        <li> 8.7% falsely believe that prescription drugs can slow disease progression.
                        </li>
                        <li>
                            47.8% understood that people with Alzheimer's eventually need 24-hour supervision.
                        </li>
                        <li>44% agreed that psychotherapy can help in early stages.
                        </li>
                        <li>83% incorrectly believed reminding patients about repetition is helpful.
                        </li>
                    </ul>
                </li>
                <li>
                    Social Perceptions:
                    <ul>
                        <li>
                            Some survey questions on social attitudes (e.g., care in state-run nursing homes, embarrassment, and social participation) were left unanswered, possibly indicating hesitation in discussing societal stigma.

                        </li>
                    </ul>
                </li>
            </ul>

            <p>The survey highlights significant misconceptions about Alzheimer's disease, particularly regarding risk factors, symptoms, and treatment. Educational efforts are needed to correct these misunderstandings and promote better awareness and early detection.
            </p>
        </div>

        <hr>

        <div id="genes">
            <h2>Genetics</h2>
            <h3>Key genes associated with AD</h3>
            <table id="genetics_table" style="border: 1px solid black;">
                <tr>
                    <th style="border: 1px solid black;">Sr. No.</th>
                    <th style="border: 1px solid black;">Gene Name</th>
                    <th style="border: 1px solid black;">Link to Source</th>
                </tr>

                <tr>
                    <td style="border: 1px solid black;">1</td>
                    <td style="border: 1px solid black;">Gene 1</td>
                    <td style="border: 1px solid black;"><a href="">Link 1</a></td>
                </tr>
                
            </table>
        </div>

        <hr>

        <div id="proteins">
            <h2>Proteins & Networks</h2>
            <h3><a id="protein_interaction" href="https://string-db.org/cgi/network?taskId=bz6Um76I4m8l&sessionId=bLvZhWBckv0J">Protein Interaction network using¬†StringDB</a></h3>
            <!-- <table id="genetics_table" style="border: 1px solid black;">
                <tr>
                    <th style="border: 1px solid black;">Sr. No.</th>
                    <th style="border: 1px solid black;">Protein Name</th>
                    <th style="border: 1px solid black;">Link to Source</th>
                </tr>

                <tr>
                    <td style="border: 1px solid black;">1</td>
                    <td style="border: 1px solid black;">Protein 1</td>
                    <td style="border: 1px solid black;"><a href="">Link 1</a></td>
                </tr> 
            </table> -->

            <img id="ppi_network" src="images/proteins.jpg" alt="">
        </div>

        <hr>

        <div id="pathways">
            <h2>Pathways</h2>
            <img id="pathway_img" src="images/pathway.jpg"><br>
            <a id="pathway_kegg" href="https://www.kegg.jp/entry/H00056">Alzheimer's Disease Pathway using¬†KEGG</a>
        </div>

        <hr>

        <div id="drugs">
            <h2>Drugs & Treatments</h2>
            <h3>Here is a list of FDA-approved drugs for the treatment of Alzheimer's disease:
            </h3>
            <p>For Mild to Moderate Alzheimer's Disease
            </p>
            <ol>
                <li><a id="inhibitors1" href="#">Cholinesterase Inhibitors:</a>
                <ul>
                    <li>Donepezil: Prevents the breakdown of acetylcholine. Can treat mild, moderate, and severe Alzheimer's.</li>
                    <li>Galantamine: Reduces the breakdown of acetylcholine and stimulates released acetylcholine.</li>
                    <li>Rivastigmine: Prevents the breakdown of acetylcholine and butyrylcholine.</li>
                </ul></li>
                <li><a id="inhibitors2" href="#">Combination Medications:</a>
                <ul>
                    <li>Memantine and Donepezil: Combines the NMDA antagonist memantine, which regulates glutamate, with donepezil.
                    </li>
                </ul></li>
            </ol>

            <p>For Moderate to Severe Alzheimer's Disease
            </p>

            <ol>
                <li>Memantine: An NMDA antagonist that helps regulate glutamate levels to prevent brain cell death.
                </li>
                <li>Rivastigmine Patch: A patch version of rivastigmine suitable for those who prefer not to take oral medications.
                </li>
                <li>Donepezil (also for moderate to severe).
                </li>
            </ol>

            <p>Immunotherapy for Early Alzheimer's Disease
            </p>

            <ol>
                <li> Lecanemab: Targets beta-amyloid plaques to reduce cognitive decline in early Alzheimer's.
                </li>
                <li>Donanemab: Similar to lecanemab, it targets beta-amyloid to help reduce plaques.
                </li>
            </ol>

            <p>Additional Treatments
            </p>
            <ul><li>Brexpiprazole: An atypical antipsychotic used to treat agitation associated with Alzheimer's.
            </li></ul>

            <p>
                These medications can help manage cognitive and behavioral symptoms, slowing disease progression and maintaining function for longer¬†periods.
            </p>

            <img id="drug_img" src="images/drugs.jpg" alt=""><br>
            <a id="references" href="https://www.nia.nih.gov/health/alzheimers-treatment/how-alzheimers-disease-treated#:~:text=Lecanemab%20and%20donanemab%20are%20FDA,hallmark%20brain%20changes%20in%20Alzheimer's.">References</a>
        </div>

        <hr>

        <div id="guide">
            <h2>Caregiver Guide</h2>
            <h3>Essential caregiving tips and resources </h3>
            <ul>
                <li><a id="tip_1" href="https://www.alzheimers.gov/life-with-dementia/tips-caregivers">
                    Tips for Caregivers and Families of People With Dementia</a>
                </li>
                <li><a id="tip_2" href="https://www.nia.nih.gov/health/alzheimers-caregiving/adapting-activities-people-alzheimers-disease">
                    Adapting Activities for People With Alzheimer's Disease</a>
                </li>
            </ul>
            <object id="pdf" type="application/pdf" data="images/Neutral Minimalist Aesthetic Finance Basics For Women Guide Ebook Cover.pdf" ></object>
        </div>

        <hr>

        <div id="support">
            <h2>Support & Helplines</h2>
            <h3> Care centers and emergency contacts </h3>
            
            <ul>
                <li><a id="center1" href="#">center 1</a></li>
                <li><a id="center2" href="#">center 2</a></li>
            </ul>
        </div>

    </main>

    <div id="footer">
        End
    </div>

    <!-- <div id="footer_container">
        <div id="footer">
            Footer Content
        </div>
    </div> -->



    <script>
        const resizeBtn = document.querySelector('[data-resize-btn]');

        resizeBtn.addEventListener('click', function(e){
            e.preventDefault();
            document.body.classList.toggle('sb-expanded');
        });


        function changeFunc() {
            var selectBox = document.getElementById("selectBox");
            var selectedValue = selectBox.options[selectBox.selectedIndex].value;
            var url = document.querySelector("#about_img");

            if(selectedValue=="eng"){
                document.getElementById("about_ad_h2").textContent="About Alzheimer's";
                // document.getElementById("about_ad_h3_1").textContent="Understanding the disease";
                // document.getElementById("about_ad_p1").textContent="Alzheimer‚Äôs Disease (AD) is a progressive neurodegenerative disorder that primarily affects memory, thinking, and behavior. It is the most common cause of dementia, impacting millions worldwide.";
                // document.getElementById("about_ad_h3_2").textContent="What happens in AD";
                // document.getElementById("about_ad_p2").textContent="Accumulation of beta-amyloid plaques and tau tangles in the brain. Loss of neuronal connections and brain cell death. Gradual decline in cognitive functions, leading to memory loss and confusion.";
                // document.getElementById("about_ad_h3_3").textContent="Why does it matter?";
                // document.getElementById("about_ad_p3").textContent="No cure currently exists, and treatments only manage symptoms. Early detection can help slow disease progression and improve quality¬†of¬†life.";
                document.getElementById("about_ad_h3_4").textContent="Summary of the paper on Alzheimer‚Äôs Disease";
                document.getElementById("about_ad_h4_1").textContent="Population Impact";
                document.getElementById("about_ad_h4_2").textContent="Disease Overview";
                document.getElementById("about_ad_h4_3").textContent="Risk Factors";
                document.getElementById("about_ad_h4_4").textContent="Pathology & Mechanisms";
                document.getElementById("about_ad_h4_5").textContent="Diagnosis & Drug Development";
                document.getElementById("about_ad_h4_6").textContent="APOE4 & Alzheimer‚Äôs Disease";
                document.getElementById("about_ad_h4_7").textContent="Sex Differences in Alzheimer‚Äôs Disease";
                document.getElementById("about_ad_h4_8").textContent="Epigenetic Clocks & Alzheimer‚Äôs Disease";

                document.getElementById("about_ad_p_1").innerHTML="Globally, 32.3 million people have Alzheimer's dementia (11.4 million men, 20.9 million women).<br />In Europe, 6.9 million people are affected (1.9 million men, 5.0 million women).<br />In the U.S., 6.9 million Americans aged 65+ have AD, projected to reach 13.8 million by 2060 without medical breakthroughs.";
                document.getElementById("about_ad_p_2").innerHTML="Alzheimer‚Äôs disease (AD) is a neurodegenerative disorder marked by:<br>Œ≤-amyloid (AŒ≤) plaques and hyperphosphorylated tau (pTau) tangles<br>Memory loss and cognitive decline<br>Unclear disease mechanisms and lack of treatments to halt progression";
                document.getElementById("about_ad_p_3").innerHTML="‚úÖGenetics:<br>APOE4 is the strongest genetic risk factor for AD.<br>Familial AD (FAD) is linked to mutations in APP, PSEN1, and PSEN2 genes.";
                document.getElementById("about_ad_p_4").innerHTML="‚úÖEnvironmental & Metabolic Factors:<br>    Aging, inflammation, infections, diabetes, and lifestyle factors contribute to AD.";
                document.getElementById("about_ad_p_5").innerHTML="AŒ≤ Accumulation: Impaired clearance leads to neurotoxicity and inflammation.<br>Tau Pathology: Abnormal tau aggregation spreads neurodegeneration.<br>Neuroinflammation: Microglial activation plays a role in disease progression.";
                document.getElementById("about_ad_p_6").innerHTML="üî¨Biomarkers: Studied in CSF (Cerebrospinal fluid) and peripheral blood.<br>üíä Current Drugs: Cholinesterase inhibitors and NMDA antagonists only manage symptoms.<br>üß™ Emerging Therapies: AŒ≤-targeting drugs and tau-focused treatments.";
                document.getElementById("about_ad_p_7").innerHTML="üîπ APOE4 affects lipid transport, neurovascular function, and microglial activity.<br>üîπ Carriers have an increased risk and earlier onset of AD.<br>üîπ Targeting APOE4 could lead to new therapeutic strategies.";
                document.getElementById("about_ad_p_8").innerHTML="üí° Women are more affected than men due to biological differences:<br>Hormones: Estrogen decline post-menopause increases risk.<br>Genetics: X chromosome-linked genes play a role.<br>Metabolism: Age-related Y chromosome loss is linked to neurodegeneration.<br>Research Bias: Historically male-focused, but tools like XWAS now uncover sex-specific genetic factors.";
                document.getElementById("about_ad_p_9").innerHTML="üß¨ Epigenetic clocks measure biological aging through DNA methylation patterns:<br>üìå First-generation clocks (Hannum, Horvath) estimate age but have limitations.<br>üìå Second-generation clocks (PhenoAge, GrimAge) predict health risks and lifespan.<br>üìå Third-generation clocks (DunedinPoAm, DunedinPACE) track biological aging rate.<br>üìå Brain-specific clocks (DNAmClockCortical, PCBrainAge) detect changes linked to neurodegeneration.";
                
                url.src = 'images/about_eng.jpg';
            }
            else if(selectedValue=="mar"){
                document.getElementById("about_ad_h2").textContent="About Alzheimer's in Marathi";
                // document.getElementById("about_ad_h3_1").textContent="next hi";
                // document.getElementById("about_ad_p1").textContent="next hi";
                // document.getElementById("about_ad_h3_2").textContent="next hi";
                // document.getElementById("about_ad_p2").textContent="next hi";
                // document.getElementById("about_ad_h3_3").textContent="next hi";
                // document.getElementById("about_ad_p3").textContent="next hi";

                document.getElementById("about_ad_h3_4").textContent="‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞‡§ö‡•ç‡§Ø‡§æ ‡§Ü‡§ú‡§æ‡§∞‡§æ‡§ö‡§æ ‡§∏‡§æ‡§∞‡§æ‡§Ç‡§∂";
                document.getElementById("about_ad_h4_1").textContent="‡§≤‡•ã‡§ï‡§∏‡§Ç‡§ñ‡•ç‡§Ø‡•á‡§µ‡§∞ ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ";
                document.getElementById("about_ad_h4_2").textContent="‡§∞‡•ã‡§ó‡§æ‡§ö‡§æ ‡§Ü‡§¢‡§æ‡§µ‡§æ";
                document.getElementById("about_ad_h4_3").textContent="‡§ß‡•ã‡§ï‡§æ ‡§µ‡§æ‡§¢‡§µ‡§£‡§æ‡§∞‡•á ‡§ò‡§ü‡§ï";
                document.getElementById("about_ad_h4_4").textContent="‡§∞‡•ã‡§ó‡§®‡§ø‡§∞‡•ç‡§Æ‡§ø‡§§‡•Ä ‡§Ü‡§£‡§ø ‡§Ø‡§Ç‡§§‡•ç‡§∞‡§£‡§æ";
                document.getElementById("about_ad_h4_5").textContent="‡§®‡§ø‡§¶‡§æ‡§® ‡§Ü‡§£‡§ø ‡§î‡§∑‡§ß‡•ã‡§™‡§ö‡§æ‡§∞";
                document.getElementById("about_ad_h4_6").textContent="APOE4 ‡§Ü‡§£‡§ø ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞";
                document.getElementById("about_ad_h4_7").textContent="‡§™‡•Å‡§∞‡•Å‡§∑ ‡§Ü‡§£‡§ø ‡§Æ‡§π‡§ø‡§≤‡§æ‡§Ç‡§Æ‡§ß‡•Ä‡§≤ ‡§´‡§∞‡§ï";
                document.getElementById("about_ad_h4_8").textContent="‡§è‡§™‡§ø‡§ú‡•á‡§®‡•á‡§ü‡§ø‡§ï ‡§ï‡•ç‡§≤‡•â‡§ï‡•ç‡§∏ ‡§Ü‡§£‡§ø ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞";

                document.getElementById("about_ad_p_1").innerHTML="‡§ú‡§ó‡§≠‡§∞‡§æ‡§§ 32.3 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑ ‡§≤‡•ã‡§ï‡§æ‡§Ç‡§®‡§æ ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞ ‡§°‡§ø‡§Æ‡•á‡§Ç‡§∂‡§ø‡§Ø‡§æ ‡§Ü‡§π‡•á (11.4 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑ ‡§™‡•Å‡§∞‡•Å‡§∑, 20.9 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑ ‡§Æ‡§π‡§ø‡§≤‡§æ).<br>‡§Ø‡•Å‡§∞‡•ã‡§™‡§Æ‡§ß‡•ç‡§Ø‡•á, 6.9 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑ ‡§≤‡•ã‡§ï ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ‡§ø‡§§ ‡§Ü‡§π‡•á‡§§ (1.9 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑ ‡§™‡•Å‡§∞‡•Å‡§∑, 5.0 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑ ‡§Æ‡§π‡§ø‡§≤‡§æ).<br>‡§Ö‡§Æ‡•á‡§∞‡§ø‡§ï‡•á‡§§, 6.9 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑ 65+ ‡§µ‡§Ø‡•ã‡§ó‡§ü‡§æ‡§§‡•Ä‡§≤ ‡§®‡§æ‡§ó‡§∞‡§ø‡§ï‡§æ‡§Ç‡§®‡§æ ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞ ‡§Ü‡§π‡•á, ‡§Ü‡§£‡§ø 2060 ‡§™‡§∞‡•ç‡§Ø‡§Ç‡§§ 13.8 ‡§¶‡§∂‡§≤‡§ï‡•ç‡§∑‡§æ‡§Ç‡§™‡§∞‡•ç‡§Ø‡§Ç‡§§ ‡§™‡•ã‡§π‡•ã‡§ö‡§£‡•ç‡§Ø‡§æ‡§ö‡•Ä ‡§∂‡§ï‡•ç‡§Ø‡§§‡§æ ‡§Ü‡§π‡•á.";
                document.getElementById("about_ad_p_2").innerHTML="‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞ ‡§π‡§æ ‡§Æ‡§∏‡•ç‡§§‡§ø‡§∑‡•ç‡§ï‡§æ‡§ö‡•ç‡§Ø‡§æ ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§°‡§ø‡§ú‡§®‡§∞‡•á‡§ü‡§ø‡§µ‡•ç‡§π ‡§Ü‡§ú‡§æ‡§∞‡§æ‡§Ç‡§™‡•à‡§ï‡•Ä ‡§è‡§ï ‡§Ö‡§∏‡•Ç‡§® ‡§§‡•ç‡§Ø‡§æ‡§Æ‡§ß‡•ç‡§Ø‡•á:Œ≤-‡§Ö‡§Æ‡§æ‡§Ø‡§≤‡•â‡§à‡§° (AŒ≤) ‡§™‡•ç‡§≤‡•Ö‡§ï‡•ç‡§∏ ‡§Ü‡§£‡§ø ‡§π‡§æ‡§Ø‡§™‡§∞‡§´‡•â‡§∏‡•ç‡§´‡•ã‡§∞‡§ø‡§≤‡•á‡§ü‡•á‡§° ‡§ü‡§æ‡§ä (pTau) ‡§ü‡•Ö‡§Ç‡§ó‡§≤‡•ç‡§∏ ‡§§‡§Ø‡§æ‡§∞ ‡§π‡•ã‡§§‡§æ‡§§.<br>‡§∏‡•ç‡§Æ‡§∞‡§£‡§∂‡§ï‡•ç‡§§‡•Ä ‡§Ü‡§£‡§ø ‡§∏‡§Ç‡§ú‡•ç‡§û‡§æ‡§®‡§æ‡§§‡•ç‡§Æ‡§ï ‡§ò‡§ü ‡§π‡•ã‡§§‡•á.<br>‡§∞‡•ã‡§ó‡§æ‡§ö‡•Ä ‡§®‡•á‡§Æ‡§ï‡•Ä ‡§ï‡§æ‡§∞‡§£‡•á ‡§Ö‡§ú‡•Ç‡§®‡§π‡•Ä ‡§Ö‡§∏‡•ç‡§™‡§∑‡•ç‡§ü ‡§Ö‡§∏‡•Ç‡§® ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ‡•Ä ‡§â‡§™‡§ö‡§æ‡§∞ ‡§®‡§æ‡§π‡•Ä‡§§.";
                document.getElementById("about_ad_p_3").innerHTML="‚úÖ ‡§Ö‡§®‡•Å‡§µ‡§Ç‡§∂‡§ø‡§ï‡§§‡§æ:<br>APOE4 ‡§π‡§æ ‡§∏‡§∞‡•ç‡§µ‡§æ‡§§ ‡§Æ‡•ã‡§†‡§æ ‡§Ö‡§®‡•Å‡§µ‡§æ‡§Ç‡§∂‡§ø‡§ï ‡§ß‡•ã‡§ï‡§æ ‡§Ü‡§π‡•á.<br>‡§´‡•Ö‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§≤ AD (FAD) ‡§π‡•á APP, PSEN1 ‡§Ü‡§£‡§ø PSEN2 ‡§ú‡§®‡•Å‡§ï‡•Ä‡§Ø ‡§â‡§§‡•ç‡§™‡§∞‡§ø‡§µ‡§∞‡•ç‡§§‡§®‡§æ‡§Ç‡§∂‡•Ä ‡§∏‡§Ç‡§¨‡§Ç‡§ß‡§ø‡§§ ‡§Ü‡§π‡•á.";
                document.getElementById("about_ad_p_4").innerHTML="‚úÖ ‡§™‡§∞‡•ç‡§Ø‡§æ‡§µ‡§∞‡§£‡•Ä‡§Ø ‡§µ ‡§ö‡§Ø‡§æ‡§™‡§ö‡§Ø ‡§ò‡§ü‡§ï:<br>‡§µ‡•É‡§¶‡•ç‡§ß‡§§‡•ç‡§µ, ‡§ú‡§≥‡§ú‡§≥ (‡§á‡§®‡•ç‡§´‡•ç‡§≤‡•Ö‡§Æ‡•á‡§∂‡§®), ‡§∏‡§Ç‡§∏‡§∞‡•ç‡§ó, ‡§Æ‡§ß‡•Å‡§Æ‡•á‡§π ‡§Ü‡§£‡§ø ‡§ú‡•Ä‡§µ‡§®‡§∂‡•à‡§≤‡•Ä ‡§Ø‡§æ ‡§ó‡•ã‡§∑‡•ç‡§ü‡•Ä ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞ ‡§µ‡§æ‡§¢‡§µ‡§§‡§æ‡§§.";
                document.getElementById("about_ad_p_5").innerHTML="üß† AŒ≤ ‡§∏‡§Ç‡§ö‡§Ø: ‡§§‡•ã ‡§Æ‡§∏‡•ç‡§§‡§ø‡§∑‡•ç‡§ï‡§æ‡§∏‡§æ‡§†‡•Ä ‡§µ‡§ø‡§∑‡§æ‡§∞‡•Ä ‡§†‡§∞‡§§‡•ã ‡§Ü‡§£‡§ø ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§á‡§®‡•ç‡§´‡•ç‡§≤‡•á‡§Æ‡•á‡§∂‡§® ‡§µ‡§æ‡§¢‡§µ‡§§‡•ã.<br>üß† ‡§ü‡§æ‡§ä ‡§™‡•Ö‡§•‡•â‡§≤‡•â‡§ú‡•Ä: ‡§ü‡§æ‡§ä ‡§™‡•ç‡§∞‡§•‡§ø‡§®‡§æ‡§Ç‡§ö‡§æ ‡§Ö‡§∏‡§æ‡§Æ‡§æ‡§®‡•ç‡§Ø ‡§∏‡§Ç‡§ö‡§Ø ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§°‡§ø‡§ú‡§®‡§∞‡•á‡§∂‡§®‡§≤‡§æ ‡§ï‡§æ‡§∞‡§£‡•Ä‡§≠‡•Ç‡§§ ‡§†‡§∞‡§§‡•ã.<br>üß† ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§á‡§®‡•ç‡§´‡•ç‡§≤‡•á‡§Æ‡•á‡§∂‡§®: ‡§Æ‡§æ‡§Ø‡§ï‡•ç‡§∞‡•ã‡§ó‡•ç‡§≤‡§ø‡§Ø‡§æ ‡§™‡•á‡§∂‡•Ä ‡§∏‡§ï‡•ç‡§∞‡§ø‡§Ø ‡§π‡•ã‡§ä‡§® ‡§∞‡•ã‡§ó ‡§µ‡§æ‡§¢‡§µ‡§§‡§æ‡§§.";
                document.getElementById("about_ad_p_6").innerHTML="üî¨ ‡§¨‡§æ‡§Ø‡•ã‡§Æ‡§æ‡§∞‡•ç‡§ï‡§∞‡•ç‡§∏: CSF (‡§∏‡§∞‡•á‡§¨‡•ç‡§∞‡•ã‡§∏‡•ç‡§™‡§æ‡§Ø‡§®‡§≤ ‡§´‡•ç‡§≤‡•Å‡§à‡§°) ‡§Ü‡§£‡§ø ‡§∞‡§ï‡•ç‡§§‡§æ‡§§‡•Ä‡§≤ ‡§¨‡§æ‡§Ø‡•ã‡§Æ‡§æ‡§∞‡•ç‡§ï‡§∞‡•ç‡§∏ ‡§Ö‡§≠‡•ç‡§Ø‡§æ‡§∏‡§æ‡§§ ‡§Ü‡§π‡•á‡§§.<br>üíä ‡§∏‡§ß‡•ç‡§Ø‡§æ‡§ö‡•á ‡§î‡§∑‡§ß‡•á: ‡§ï‡•ã‡§≤‡§ø‡§®‡•á‡§∏‡•ç‡§ü‡•ç‡§∞‡•á‡§∏ ‡§á‡§®‡§π‡§ø‡§¨‡§ø‡§ü‡§∞ ‡§Ü‡§£‡§ø NMDA ‡§Ö‡§Å‡§ü‡•Ö‡§ó‡•ã‡§®‡§ø‡§∏‡•ç‡§ü ‡§´‡§ï‡•ç‡§§ ‡§≤‡§ï‡•ç‡§∑‡§£‡•á ‡§®‡§ø‡§Ø‡§Ç‡§§‡•ç‡§∞‡§ø‡§§ ‡§ï‡§∞‡§§‡§æ‡§§.<br>üß™ ‡§®‡§µ‡•Ä‡§® ‡§â‡§™‡§ö‡§æ‡§∞: AŒ≤ ‡§Ü‡§£‡§ø ‡§ü‡§æ‡§ä ‡§≤‡§ï‡•ç‡§∑ ‡§ï‡§∞‡§£‡§æ‡§∞‡•Ä ‡§î‡§∑‡§ß‡•á ‡§µ‡§ø‡§ï‡§∏‡§ø‡§§ ‡§π‡•ã‡§§ ‡§Ü‡§π‡•á‡§§.";
                document.getElementById("about_ad_p_7").innerHTML="üîπ APOE4 ‡§Æ‡•á‡§Ç‡§¶‡•Ç‡§§‡•Ä‡§≤ ‡§ö‡§∞‡§¨‡•Ä ‡§µ‡§æ‡§π‡§§‡•Ç‡§ï, ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§µ‡•ç‡§π‡•Ö‡§∏‡•ç‡§ï‡•ç‡§Ø‡•Å‡§≤‡§∞ ‡§ï‡§æ‡§∞‡•ç‡§Ø ‡§Ü‡§£‡§ø ‡§Æ‡§æ‡§Ø‡§ï‡•ç‡§∞‡•ã‡§ó‡•ç‡§≤‡§ø‡§Ø‡§æ ‡§ï‡•ç‡§∞‡§ø‡§Ø‡§æ‡§ï‡§≤‡§æ‡§™‡§æ‡§Ç‡§µ‡§∞ ‡§™‡§∞‡§ø‡§£‡§æ‡§Æ ‡§ï‡§∞‡§§‡•ã.<br>üîπ APOE4 ‡§µ‡§æ‡§π‡§ï‡§æ‡§Ç‡§Æ‡§ß‡•ç‡§Ø‡•á ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞ ‡§π‡•ã‡§£‡•ç‡§Ø‡§æ‡§ö‡§æ ‡§ß‡•ã‡§ï‡§æ ‡§Ü‡§£‡§ø ‡§≤‡§µ‡§ï‡§∞ ‡§∏‡•Å‡§∞‡•Å‡§µ‡§æ‡§§ ‡§π‡•ã‡§£‡•ç‡§Ø‡§æ‡§ö‡•Ä ‡§∂‡§ï‡•ç‡§Ø‡§§‡§æ ‡§ú‡§æ‡§∏‡•ç‡§§ ‡§Ü‡§π‡•á.<br>üîπ APOE4 ‡§≤‡§æ ‡§≤‡§ï‡•ç‡§∑‡•ç‡§Ø ‡§ï‡§∞‡§£‡§æ‡§∞‡•á ‡§â‡§™‡§ö‡§æ‡§∞ ‡§≠‡§µ‡§ø‡§∑‡•ç‡§Ø‡§æ‡§§ ‡§´‡§æ‡§Ø‡§¶‡•á‡§∂‡•Ä‡§∞ ‡§†‡§∞‡•Ç ‡§∂‡§ï‡§§‡§æ‡§§.";
                document.getElementById("about_ad_p_8").innerHTML="üí° ‡§Æ‡§π‡§ø‡§≤‡§æ‡§Ç‡§®‡§æ ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞‡§ö‡§æ ‡§ß‡•ã‡§ï‡§æ ‡§Ö‡§ß‡§ø‡§ï ‡§Ö‡§∏‡§§‡•ã, ‡§Æ‡•Å‡§ñ‡•ç‡§Ø ‡§ï‡§æ‡§∞‡§£‡•á:<br>‡§∏‡•ç‡§ü‡•ç‡§∞‡•â‡§ú‡§®‡§ö‡•Ä ‡§ò‡§ü (‡§Æ‡•á‡§®‡•ã‡§™‡•â‡§ú ‡§®‡§Ç‡§§‡§∞ ‡§ß‡•ã‡§ï‡§æ ‡§µ‡§æ‡§¢‡§§‡•ã).<br>X ‡§ï‡•ç‡§∞‡•ã‡§Æ‡•ã‡§∏‡•ã‡§Æ‡§∂‡•Ä ‡§∏‡§Ç‡§¨‡§Ç‡§ß‡§ø‡§§ ‡§Ö‡§®‡•Å‡§µ‡§æ‡§Ç‡§∂‡§ø‡§ï ‡§ò‡§ü‡§ï.<br>Y ‡§ï‡•ç‡§∞‡•ã‡§Æ‡•ã‡§∏‡•ã‡§Æ‡§ö‡•á ‡§µ‡§Ø‡§æ‡§∏‡•ã‡§¨‡§§ ‡§≤‡•ã‡§™, ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§°‡§ø‡§ú‡§®‡§∞‡•á‡§∂‡§®‡§∂‡•Ä ‡§∏‡§Ç‡§¨‡§Ç‡§ß.<br>‡§Æ‡§æ‡§ó‡•Ä‡§≤ ‡§∏‡§Ç‡§∂‡•ã‡§ß‡§® ‡§™‡•Å‡§∞‡•Å‡§∑‡§æ‡§Ç‡§µ‡§∞ ‡§ï‡•á‡§Ç‡§¶‡•ç‡§∞‡§ø‡§§ ‡§π‡•ã‡§§‡•á, ‡§™‡§£ ‡§Ü‡§§‡§æ XWAS ‡§∏‡§æ‡§∞‡§ñ‡•Ä ‡§∏‡§æ‡§ß‡§®‡•á ‡§≤‡§ø‡§Ç‡§ó-‡§µ‡§ø‡§∂‡§ø‡§∑‡•ç‡§ü ‡§ò‡§ü‡§ï ‡§ì‡§≥‡§ñ‡§§ ‡§Ü‡§π‡•á‡§§.";
                document.getElementById("about_ad_p_9").innerHTML="üß¨ ‡§è‡§™‡§ø‡§ú‡•á‡§®‡•á‡§ü‡§ø‡§ï ‡§ï‡•ç‡§≤‡•â‡§ï‡•ç‡§∏ DNA ‡§Æ‡§ø‡§•‡§æ‡§á‡§≤‡•á‡§∂‡§® ‡§™‡•Ö‡§ü‡§∞‡•ç‡§®‡§¶‡•ç‡§µ‡§æ‡§∞‡•á ‡§ú‡•à‡§µ‡§ø‡§ï ‡§µ‡•É‡§¶‡•ç‡§ß‡§§‡•ç‡§µ ‡§Æ‡•ã‡§ú‡§§‡§æ‡§§.<br>üìå ‡§™‡§π‡§ø‡§≤‡•ç‡§Ø‡§æ ‡§™‡§ø‡§¢‡•Ä‡§ö‡•á ‡§ï‡•ç‡§≤‡•â‡§ï‡•ç‡§∏ (Hannum, Horvath) ‡§µ‡§Ø‡§æ‡§ö‡§æ ‡§Ö‡§Ç‡§¶‡§æ‡§ú ‡§≤‡§æ‡§µ‡§§‡§æ‡§§, ‡§™‡§£ ‡§Æ‡§∞‡•ç‡§Ø‡§æ‡§¶‡§æ ‡§Ü‡§π‡•á‡§§.<br>üìå ‡§¶‡•Å‡§∏‡§±‡•ç‡§Ø‡§æ ‡§™‡§ø‡§¢‡•Ä‡§ö‡•á ‡§ï‡•ç‡§≤‡•â‡§ï‡•ç‡§∏ (PhenoAge, GrimAge) ‡§Ü‡§∞‡•ã‡§ó‡•ç‡§Ø‡§æ‡§ö‡§æ ‡§ß‡•ã‡§ï‡§æ ‡§Ü‡§£‡§ø ‡§Ü‡§Ø‡•Å‡§∞‡•ç‡§Æ‡§æ‡§®‡§æ‡§ö‡§æ ‡§Ö‡§Ç‡§¶‡§æ‡§ú ‡§≤‡§æ‡§µ‡§§‡§æ‡§§.<br>üìå ‡§§‡§ø‡§∏‡§±‡•ç‡§Ø‡§æ ‡§™‡§ø‡§¢‡•Ä‡§ö‡•á ‡§ï‡•ç‡§≤‡•â‡§ï‡•ç‡§∏ (DunedinPoAm, DunedinPACE) ‡§ú‡•à‡§µ‡§ø‡§ï ‡§µ‡•É‡§¶‡•ç‡§ß‡§§‡•ç‡§µ‡§æ‡§ö‡§æ ‡§µ‡•á‡§ó ‡§Æ‡•ã‡§ú‡§§‡§æ‡§§.<br>üìå ‡§Æ‡•á‡§Ç‡§¶‡•Ç-‡§µ‡§ø‡§∂‡§ø‡§∑‡•ç‡§ü ‡§ï‡•ç‡§≤‡•â‡§ï‡•ç‡§∏ (DNAmClockCortical, PCBrainAge) ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§°‡§ø‡§ú‡§®‡§∞‡•á‡§∂‡§® ‡§ì‡§≥‡§ñ‡§§‡§æ‡§§.";

                url.src = 'images/about_mar.jpg';
            }
            else{
                document.getElementById("about_ad_h2").textContent="About Alzheimer's in Hindi";
                // document.getElementById("about_ad_h3_1").textContent="next hi";
                // document.getElementById("about_ad_p1").textContent="next hi";
                // document.getElementById("about_ad_h3_2").textContent="next hi";
                // document.getElementById("about_ad_p2").textContent="next hi";
                // document.getElementById("about_ad_h3_3").textContent="next hi";
                // document.getElementById("about_ad_p3").textContent="next hi";

                document.getElementById("about_ad_h3_4").textContent="‡§Ö‡§≤‡•ç‡§ù‡§æ‡§Ø‡§Æ‡§∞ ‡§∞‡•ã‡§ó ‡§ï‡§æ ‡§∏‡§æ‡§∞‡§æ‡§Ç‡§∂";
                document.getElementById("about_ad_h4_1").textContent="‡§ú‡§®‡§∏‡§Ç‡§ñ‡•ç‡§Ø‡§æ ‡§™‡§∞ ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ";
                document.getElementById("about_ad_h4_2").textContent="‡§∞‡•ã‡§ó ‡§ï‡§æ ‡§Ö‡§µ‡§≤‡•ã‡§ï‡§®";
                document.getElementById("about_ad_h4_3").textContent="‡§ú‡•ã‡§ñ‡§ø‡§Æ ‡§ï‡§æ‡§∞‡§ï";
                document.getElementById("about_ad_h4_4").textContent="‡§∞‡•ã‡§ó ‡§ï‡•Ä ‡§™‡•ç‡§∞‡§ï‡•ç‡§∞‡§ø‡§Ø‡§æ ‡§î‡§∞ ‡§§‡§Ç‡§§‡•ç‡§∞";
                document.getElementById("about_ad_h4_5").textContent="‡§®‡§ø‡§¶‡§æ‡§® ‡§î‡§∞ ‡§â‡§™‡§ö‡§æ‡§∞";
                document.getElementById("about_ad_h4_6").textContent="APOE4 ‡§î‡§∞ ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§á‡§Æ‡§∞";
                document.getElementById("about_ad_h4_7").textContent="‡§≤‡§ø‡§Ç‡§ó ‡§ï‡•á ‡§Ö‡§®‡•Å‡§∏‡§æ‡§∞ ‡§Ö‡§Ç‡§§‡§∞";
                document.getElementById("about_ad_h4_8").textContent="‡§è‡§™‡§ø‡§ú‡•á‡§®‡•á‡§ü‡§ø‡§ï ‡§ï‡•ç‡§≤‡•â‡§ï‡•ç‡§∏";

                document.getElementById("about_ad_p_1").innerHTML="‡§¶‡•Å‡§®‡§ø‡§Ø‡§æ ‡§Æ‡•á‡§Ç 32.3 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® ‡§≤‡•ã‡§ó ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§á‡§Æ‡§∞ ‡§°‡§ø‡§Æ‡•á‡§Ç‡§∂‡§ø‡§Ø‡§æ ‡§∏‡•á ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ‡§ø‡§§ ‡§π‡•à‡§Ç (11.4 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® ‡§™‡•Å‡§∞‡•Å‡§∑, 20.9 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® ‡§Æ‡§π‡§ø‡§≤‡§æ‡§è‡§Ç)‡•§<br>‡§Ø‡•Ç‡§∞‡•ã‡§™ ‡§Æ‡•á‡§Ç, 6.9 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® ‡§≤‡•ã‡§ó ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ‡§ø‡§§ ‡§π‡•à‡§Ç (1.9 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® ‡§™‡•Å‡§∞‡•Å‡§∑, 5.0 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® ‡§Æ‡§π‡§ø‡§≤‡§æ‡§è‡§Ç)‡•§<br>‡§Ö‡§Æ‡•á‡§∞‡§ø‡§ï‡§æ ‡§Æ‡•á‡§Ç, 6.9 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® 65+ ‡§â‡§Æ‡•ç‡§∞ ‡§ï‡•á ‡§≤‡•ã‡§ó ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§á‡§Æ‡§∞ ‡§∏‡•á ‡§™‡•Ä‡§°‡§º‡§ø‡§§ ‡§π‡•à‡§Ç, ‡§î‡§∞ 2060 ‡§§‡§ï 13.8 ‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§® ‡§§‡§ï ‡§¨‡§¢‡§º‡§®‡•á ‡§ï‡§æ ‡§Ö‡§®‡•Å‡§Æ‡§æ‡§® ‡§π‡•à‡•§";
                document.getElementById("about_ad_p_2").innerHTML="‡§Ö‡§≤‡•ç‡§ù‡§æ‡§á‡§Æ‡§∞ ‡§è‡§ï ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§°‡•Ä‡§ú‡•á‡§®‡•á‡§∞‡•á‡§ü‡§ø‡§µ ‡§¨‡•Ä‡§Æ‡§æ‡§∞‡•Ä ‡§π‡•à, ‡§ú‡§ø‡§∏‡§Æ‡•á‡§Ç:<br>Œ≤-‡§Ö‡§Æ‡§æ‡§Ø‡§≤‡•â‡§á‡§° (AŒ≤) ‡§™‡•ç‡§≤‡§æ‡§ï‡•ç‡§∏ ‡§î‡§∞ ‡§π‡§æ‡§á‡§™‡§∞‡§´‡•â‡§∏‡•ç‡§´‡•ã‡§∞‡§æ‡§á‡§≤‡•á‡§ü‡•á‡§° ‡§ü‡§æ‡§ä (pTau) ‡§ü‡§Ç‡§ó‡§≤‡•ç‡§∏ ‡§¨‡§®‡§§‡•á ‡§π‡•à‡§Ç‡•§<br>‡§∏‡•ç‡§Æ‡§∞‡§£‡§∂‡§ï‡•ç‡§§‡§ø ‡§î‡§∞ ‡§∏‡§Ç‡§ú‡•ç‡§û‡§æ‡§®‡§æ‡§§‡•ç‡§Æ‡§ï ‡§ï‡•ç‡§∑‡§Æ‡§§‡§æ ‡§ï‡§æ ‡§π‡•ç‡§∞‡§æ‡§∏ ‡§π‡•ã‡§§‡§æ ‡§π‡•à‡•§<br>‡§∞‡•ã‡§ó ‡§ï‡•Ä ‡§∏‡§π‡•Ä ‡§µ‡§ú‡§π ‡§∏‡•ç‡§™‡§∑‡•ç‡§ü ‡§®‡§π‡•Ä‡§Ç ‡§π‡•à ‡§î‡§∞ ‡§ï‡•ã‡§à ‡§á‡§≤‡§æ‡§ú ‡§®‡§π‡•Ä‡§Ç ‡§π‡•à‡•§";
                document.getElementById("about_ad_p_3").innerHTML="‚úÖ ‡§ú‡•á‡§®‡•á‡§ü‡§ø‡§ï‡•ç‡§∏:<br>APOE4 ‡§∏‡§¨‡§∏‡•á ‡§¨‡§°‡§º‡§æ ‡§Ü‡§®‡•Å‡§µ‡§Ç‡§∂‡§ø‡§ï ‡§ú‡•ã‡§ñ‡§ø‡§Æ ‡§ï‡§æ‡§∞‡§ï ‡§π‡•à‡•§<br>‡§´‡•à‡§Æ‡§ø‡§≤‡§ø‡§Ø‡§≤ AD (FAD) APP, PSEN1 ‡§î‡§∞ PSEN2 ‡§ú‡•Ä‡§® ‡§Æ‡•á‡§Ç ‡§Æ‡•ç‡§Ø‡•Ç‡§ü‡•á‡§∂‡§® ‡§∏‡•á ‡§ú‡•Å‡§°‡§º‡§æ ‡§π‡•à‡•§";
                document.getElementById("about_ad_p_4").innerHTML="‚úÖ ‡§™‡§∞‡•ç‡§Ø‡§æ‡§µ‡§∞‡§£‡•Ä‡§Ø ‡§î‡§∞ ‡§Æ‡•á‡§ü‡§æ‡§¨‡•ã‡§≤‡§ø‡§ï ‡§ï‡§æ‡§∞‡§ï:<br>‡§â‡§Æ‡•ç‡§∞ ‡§¨‡§¢‡§º‡§®‡§æ, ‡§∏‡•Ç‡§ú‡§®, ‡§∏‡§Ç‡§ï‡•ç‡§∞‡§Æ‡§£, ‡§Æ‡§ß‡•Å‡§Æ‡•á‡§π ‡§î‡§∞ ‡§ú‡•Ä‡§µ‡§®‡§∂‡•à‡§≤‡•Ä ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§á‡§Æ‡§∞ ‡§ï‡•ã ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ‡§ø‡§§ ‡§ï‡§∞‡§§‡•á ‡§π‡•à‡§Ç‡•§";
                document.getElementById("about_ad_p_5").innerHTML="üß† AŒ≤ ‡§∏‡§Ç‡§ö‡§Ø: ‡§ñ‡§∞‡§æ‡§¨ ‡§®‡§ø‡§ï‡§æ‡§∏‡•Ä ‡§∏‡•á ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§ü‡•â‡§ï‡•ç‡§∏‡§ø‡§∏‡§ø‡§ü‡•Ä ‡§î‡§∞ ‡§∏‡•Ç‡§ú‡§® ‡§π‡•ã‡§§‡•Ä ‡§π‡•à‡•§<br>üß† ‡§ü‡§æ‡§ä ‡§™‡•à‡§•‡•ã‡§≤‡•â‡§ú‡•Ä: ‡§ü‡§æ‡§ä ‡§™‡•ç‡§∞‡•ã‡§ü‡•Ä‡§® ‡§ï‡§æ ‡§Ö‡§∏‡§æ‡§Æ‡§æ‡§®‡•ç‡§Ø ‡§∏‡§Ç‡§ö‡§Ø ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§°‡•Ä‡§ú‡•á‡§®‡•á‡§∞‡•á‡§∂‡§® ‡§¨‡§¢‡§º‡§æ‡§§‡§æ ‡§π‡•à‡•§<br>üß† ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§á‡§®‡•ç‡§´‡•ç‡§≤‡•á‡§Æ‡•á‡§∂‡§®: ‡§Æ‡§æ‡§á‡§ï‡•ç‡§∞‡•ã‡§ó‡•ç‡§≤‡§ø‡§Ø‡§æ ‡§ï‡•ã‡§∂‡§ø‡§ï‡§æ‡§è‡§Ç ‡§∏‡§ï‡•ç‡§∞‡§ø‡§Ø ‡§π‡•ã‡§ï‡§∞ ‡§¨‡•Ä‡§Æ‡§æ‡§∞‡•Ä ‡§ï‡•ã ‡§¨‡§¢‡§º‡§æ‡§§‡•Ä ‡§π‡•à‡§Ç‡•§";
                document.getElementById("about_ad_p_6").innerHTML="üî¨ ‡§¨‡§æ‡§Ø‡•ã‡§Æ‡§æ‡§∞‡•ç‡§ï‡§∞: CSF (‡§∏‡•á‡§∞‡•á‡§¨‡•ç‡§∞‡•ã‡§∏‡•ç‡§™‡§æ‡§á‡§®‡§≤ ‡§´‡•ç‡§≤‡•Å‡§á‡§°) ‡§î‡§∞ ‡§∞‡§ï‡•ç‡§§ ‡§¨‡§æ‡§Ø‡•ã‡§Æ‡§æ‡§∞‡•ç‡§ï‡§∞ ‡§Ö‡§ß‡•ç‡§Ø‡§Ø‡§® ‡§Æ‡•á‡§Ç ‡§π‡•à‡§Ç‡•§<br>üíä ‡§µ‡§∞‡•ç‡§§‡§Æ‡§æ‡§® ‡§¶‡§µ‡§æ‡§è‡§Ç: ‡§ï‡•ã‡§≤‡§ø‡§®‡•á‡§∏‡•ç‡§ü‡§∞‡•á‡§ú ‡§á‡§®‡§π‡§ø‡§¨‡§ø‡§ü‡§∞ ‡§î‡§∞ NMDA ‡§è‡§Ç‡§ü‡§æ‡§ó‡•ã‡§®‡§ø‡§∏‡•ç‡§ü ‡§ï‡•á‡§µ‡§≤ ‡§≤‡§ï‡•ç‡§∑‡§£‡•ã‡§Ç ‡§ï‡§æ ‡§á‡§≤‡§æ‡§ú ‡§ï‡§∞‡§§‡•á ‡§π‡•à‡§Ç‡•§<br>üß™ ‡§®‡§è ‡§â‡§™‡§ö‡§æ‡§∞: AŒ≤ ‡§î‡§∞ ‡§ü‡§æ‡§ä ‡§™‡§∞ ‡§ï‡•á‡§Ç‡§¶‡•ç‡§∞‡§ø‡§§ ‡§¶‡§µ‡§æ‡§è‡§Ç ‡§µ‡§ø‡§ï‡§∏‡§ø‡§§ ‡§π‡•ã ‡§∞‡§π‡•Ä ‡§π‡•à‡§Ç‡•§";
                document.getElementById("about_ad_p_7").innerHTML="üîπ APOE4 ‡§≤‡§ø‡§™‡§ø‡§° ‡§ü‡•ç‡§∞‡§æ‡§Ç‡§∏‡§™‡•ã‡§∞‡•ç‡§ü, ‡§®‡•ç‡§Ø‡•Ç‡§∞‡•ã‡§µ‡•à‡§∏‡•ç‡§ï‡•Å‡§≤‡§∞ ‡§ï‡§æ‡§∞‡•ç‡§Ø ‡§î‡§∞ ‡§Æ‡§æ‡§á‡§ï‡•ç‡§∞‡•ã‡§ó‡•ç‡§≤‡§ø‡§Ø‡§æ ‡§ó‡§§‡§ø‡§µ‡§ø‡§ß‡§ø ‡§ï‡•ã ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ‡§ø‡§§ ‡§ï‡§∞‡§§‡§æ ‡§π‡•à‡•§<br>üîπ APOE4 ‡§µ‡§æ‡§π‡§ï‡•ã‡§Ç ‡§Æ‡•á‡§Ç ‡§Ö‡§≤‡•ç‡§ù‡§æ‡§á‡§Æ‡§∞ ‡§ï‡§æ ‡§ú‡•ã‡§ñ‡§ø‡§Æ ‡§Ö‡§ß‡§ø‡§ï ‡§î‡§∞ ‡§∂‡•Å‡§∞‡•Å‡§Ü‡§§ ‡§ú‡§≤‡•ç‡§¶‡•Ä ‡§π‡•ã‡§§‡•Ä ‡§π‡•à‡•§";
                document.getElementById("about_ad_p_8").innerHTML="üí° ‡§Æ‡§π‡§ø‡§≤‡§æ‡§ì‡§Ç ‡§Æ‡•á‡§Ç ‡§ú‡•ã‡§ñ‡§ø‡§Æ ‡§Ö‡§ß‡§ø‡§ï ‡§π‡•à ‚Äì ‡§π‡§æ‡§∞‡•ç‡§Æ‡•ã‡§®‡§≤ ‡§î‡§∞ ‡§ú‡•á‡§®‡•á‡§ü‡§ø‡§ï ‡§ï‡§æ‡§∞‡§£‡•ã‡§Ç ‡§∏‡•á‡•§";
                document.getElementById("about_ad_p_9").innerHTML="üß¨ DNA ‡§Æ‡§ø‡§•‡§æ‡§á‡§≤‡•á‡§∂‡§® ‡§™‡•à‡§ü‡§∞‡•ç‡§® ‡§∏‡•á ‡§ú‡•à‡§µ‡§ø‡§ï ‡§â‡§Æ‡•ç‡§∞ ‡§ï‡§æ ‡§™‡§§‡§æ ‡§ö‡§≤‡§§‡§æ ‡§π‡•à‡•§";

                url.src = 'images/about_hin.jpg';
            }
        }


        function changeFunc2() {
            var selectBox = document.getElementById("selectBox2");
            var selectedValue = selectBox.options[selectBox.selectedIndex].value;
            var url = document.querySelector("#survey_form");
        

            if(selectedValue=='eng'){
                // location.reload(true);
                // document.getElementById("aware_h2").textContent="Awareness & Survey";
                // document.getElementById("aware_h3_1").textContent="Survey insights and the need for awareness";
                // document.getElementById("aware_h3_2").textContent="Survey Evaluation";
                document.getElementById("survey_form").textContent="Fill Survey Form in English";
                // document.getElementById("aware_li1").textContent="Good 154/205 : 24.9% ";
                // document.getElementById("aware_li2").textContent="Poor 51/205 : 75.1% ";
                url.href = 'https://docs.google.com/forms/d/e/1FAIpQLSf1Qo3veVBKrddcrHKCTvaTiHQCVi0uPwscwUhgrA3FA7Ocig/viewform?usp=header';
            }
            else if(selectedValue=='mar'){
                // location.reload(true);
                // document.getElementById("aware_h2").textContent="About Alzheimer's";
                // document.getElementById("aware_h3_1").textContent="About Alzheimer's";
                // document.getElementById("aware_h3_2").textContent="About Alzheimer's";
                document.getElementById("survey_form").textContent="‡§∏‡§∞‡•ç‡§µ‡•á‡§ï‡•ç‡§∑‡§£ ‡§´‡•â‡§∞‡•ç‡§Æ ‡§≠‡§∞‡§æ";
                // document.getElementById("aware_li1").textContent="About Alzheimer's";
                // document.getElementById("aware_li2").textContent="About Alzheimer's";
                url.href = 'https://forms.gle/khr19edXPZjVWbcC7';
            }
            else{
                // location.reload(true);
                // document.getElementById("aware_h2").textContent="About Alzheimer's";
                // document.getElementById("aware_h3_1").textContent="About Alzheimer's";
                // document.getElementById("aware_h3_2").textContent="About Alzheimer's";
                document.getElementById("survey_form").textContent="‡§∏‡§∞‡•ç‡§µ‡•á ‡§´‡§º‡•â‡§∞‡•ç‡§Æ ‡§≠‡§∞‡•á‡§Ç";
                // document.getElementById("aware_li1").textContent="About Alzheimer's";
                // document.getElementById("aware_li2").textContent="About Alzheimer's";
                url.href = 'https://forms.gle/2JLQSTdB5ezyD6o38';
            }
        }


    //     document.getElementById("selectBox2").onclick = function() {
    //     var link = document.getElementById("survey_form");
    //     link.setAttribute("href", "https://forms.gle/khr19edXPZjVWbcC7");
    //     return false;
    // }

        


    </script>
    
</body>
</html>